Immunolab is a Polish company that develops and implements vaccines and immunological preparations for the prevention and treatment of various diseases in animals, particularly swine and broiler infections caused by pathogenic bacteria such as E coli and Campylobacter jejuni. The company also manufactures diagnostic products, including sera for serological diagnosis of Salmonella. Immunolab's main activities include the production and sale of biological products for health and veterinary services in Poland, as well as accepting individual orders from Scientific Institutes.

Headquarters
Ul. Kladki 24
Gdansk; Pomorskie; Postal Code: 80-822

Contact Details: Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.

Website: http://www.immunolab.com.pl

Basic Information

Total Employees:

Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report to view the information.

Incorporation Date:

March 13, 2002

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

52.29%▲

Total operating revenue

-38.9%▼

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

-35.19%▼

Total Equity

-47.88%▼

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt/Equity

30.76%▲

Quick Ratio

-0.31%▼

Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. (Poland)

Similar companies